Status:
COMPLETED
Trial of a Botulinum A Toxin (Botox) Injection in the Gastrocnemius Muscle in Children With Idiopathic Toe Walking
Lead Sponsor:
University of British Columbia
Conditions:
Idiopathic Toe Walking
Eligibility:
All Genders
5-15 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to compare the effect of Botox and casting to placebo and casting for reducing toe walking problems in children who are idiopathic toe walkers.
Detailed Description
Patients who have been seen by one of the 5 paediatric orthopaedic surgeons at British Columbia's Children's Hospital and have been referred to the Shriner's gait lab for assessment of idiopathic toe ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who have been seen by one of the 5 paediatric orthopaedic surgeons at British Columbia's Children's Hospital and have been referred to the Shriner's gait lab for assessment of idiopathic toe walking
- Clinical toe walkers - toe walkers as per gait lab's definition (loss of 1st ankle rocker, early heel rise \[prior to 30% of the cycle\] and A1 kinematic data)
- Aged 5 - 15 years old
- Parents and patients educated about protocol and willing to partake
- Cooperative patient with gait analysis and injection
Exclusion
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00175669
Start Date
August 1 2007
End Date
November 1 2009
Last Update
April 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
BC Children's Hospital, Department of Orthopaedics
Vancouver, British Columbia, Canada, V6H 3V4